Biopharmaceutical Product Attributes and Biological Consequences Community

A reminder to everyone that the deadline for Programming Proposals for 2026 AAPS NBC is quickly approaching on Sep 26th.  See the announcement here: NBC - American Association of Pharmaceutical Scientists

Aaps		remove preview
NBC - American Association of Pharmaceutical Scientists Track 1: Applying Translational Principles Across the Development Lifecycle Translational medicine aims to predict the benefit/risk profile of therapeutics during both clinical development programs and individualized patient care post-approval. As biotechnology drives innovation in novel modalities, new targets, and rare diseases, optimizing translational strategies becomes increasingly complex. View this on Aaps >

As part of the Scientific Programming Committee leading "Track 1: Applying Translational Principles Across the Development Lifecycle" along with @Amritangshu Chakravarty, @Swetha Thiyagarajan, and @Joleen White, we would like to invite you to submit your programming proposals. Some focus areas of particular relevance to this group are:

• identifying clinically meaningful critical quality attributes
• using artificial intelligence (AI) in formulation and manufacturing
• evaluating the safety of new excipients and adjuvants
• modality selection matched to disease and target
• advances in delivery vectors
• clinical immunogenicity prediction
• high-content sample analysis such as high resolution mass spectrometry (HRMS)
• bioanalytical challenges with complex biologics
• challenges between early development and scale-up to commercial process
• registration with global health authorities beyond US and EMA
• lessons learned from complete response letters
• recognizing successes in work involving novel modalities

Please reach out with any questions! Looking forward to an amazing conference in San Diego next year

Hello BPABC Community, 

Please note the upcoming deadline (Sep 26th) for Programming Proposals for 2026 AAPS NBC. See the announcement here: NBC - American Association of Pharmaceutical Scientists and refer to Dr. Basiri's original message in this thread for details on focus areas of interest. These are very relevant topics, aligned with our Community's interests. Please consider submitting a proposal. Thank you. 

Warm Regards, 

Mayank

A reminder to everyone that the deadline for Programming Proposals for 2026 AAPS NBC is quickly approaching on Sep 26th.  See the announcement here: NBC - American Association of Pharmaceutical Scientists

Aaps		remove preview
NBC - American Association of Pharmaceutical Scientists Track 1: Applying Translational Principles Across the Development Lifecycle Translational medicine aims to predict the benefit/risk profile of therapeutics during both clinical development programs and individualized patient care post-approval. As biotechnology drives innovation in novel modalities, new targets, and rare diseases, optimizing translational strategies becomes increasingly complex. View this on Aaps >

As part of the Scientific Programming Committee leading "Track 1: Applying Translational Principles Across the Development Lifecycle" along with @Amritangshu Chakravarty, @Swetha Thiyagarajan, and @Joleen White, we would like to invite you to submit your programming proposals. Some focus areas of particular relevance to this group are:

• identifying clinically meaningful critical quality attributes
• using artificial intelligence (AI) in formulation and manufacturing
• evaluating the safety of new excipients and adjuvants
• modality selection matched to disease and target
• advances in delivery vectors
• clinical immunogenicity prediction
• high-content sample analysis such as high resolution mass spectrometry (HRMS)
• bioanalytical challenges with complex biologics
• challenges between early development and scale-up to commercial process
• registration with global health authorities beyond US and EMA
• lessons learned from complete response letters
• recognizing successes in work involving novel modalities

Please reach out with any questions! Looking forward to an amazing conference in San Diego next year